The Effect of Music Therapy on Dyspnea Severity and Vital Signs

Summary

This study aims to investigate the effect of music therapy on dyspnea severity and quality of life indicators in patients with Chronic Obstructive Pulmonary Disease (COPD) admitted to the intensive care unit. The study will be conducted at Isparta City Hospital and Kumluca State Hospital in Antalya, Turkey, using an experimental design. Patients will be divided into experimental and control groups, selected using randomization. Patients in the experimental group will receive music therapy in the Hüseyni maqam, while those in the control group will not receive any music therapy. Life indicators and Modified Borg Scale (MBS) values of patients in the experimental group will be recorded before, immediately after, and 30 minutes post-application. Music therapy will be administered to patients for only one day, once in the morning. Data for patients in the control group will be collected at the same time intervals. The results of this study aim to contribute to the literature on the impact of music therapy on dyspnea severity and quality of life indicators in COPD patients.

Eligibility

Inclusion Criteria:

* Being treated as a patient in intensive care.
* Being monitored with a diagnosis of COPD (Chronic Obstructive Pulmonary Disease).
* Currently undergoing treatment for dyspnea symptoms.
* Volunteering to participate in the research.
* Receiving treatment at Kumluca State Hospital.
* Receiving treatment at Isparta City Hospital.
* Being 18 years of age or older.
* Having intact consciousness and full capacity for judgment.
* Being able to read and write.
* Speaking Turkish.
* Having no communication barriers.

Exclusion Criteria:

* Decline participation in the research.
* Wish to withdraw from the study after it has started.
* Have a verbal communication barrier.
* Be under 18 years of age.
* Be receiving treatment in a unit other than intensive care.
* Have ear trauma, infection, or other ear-related conditions.
* Have hearing impairment.

Conditions3

Browse More Trials